Endocrine consequences of continuous antiestrogen therapy with tamoxifen in premenopausal women
- PMID: 110834
- PMCID: PMC372132
- DOI: 10.1172/JCI109475
Endocrine consequences of continuous antiestrogen therapy with tamoxifen in premenopausal women
Abstract
Daily administration of estrogen antagonists to premenopausal women has been incorporated into the adjuvant treatment of breast cancer. We have studied the changes in reproductive hormones, pituitary responses to hypothalamic-releasing hormones, and endometrial histology during treatment with the antiestrogen tamoxifen in five healthy, premenopausal women. These studies were carried out during one menstrual cycle before and during two cycles of antiestrogen treatment. All subjects continued to have regular menses with biphasic basal body temperature records. During treatment, estradiol (E2) levels were increased but followed the usual pattern reflecting follicular maturation and corpus luteum formation. The mean E2 concentration at the midcycle peak and during the luteal phase was twice that observed during the non-treatment cycle. By contrast, the concentrations and secretory patterns of luteinizing hormone and follicle-stimulating hormone were not greatly changed, and the gonadotropin responses to gonadotropin-releasing hormone were not suppressed. Endometrial biopsies obtained during the follicular phase of control and tamoxifen treatment cycles showed no differences whereas biopsies obtained during the luteal phase of tamoxifen cycles uniformly showed a lack of changes attributed to progesterone action with no progression of histologic changes beyond those expected on day 7-8 of the luteal phase. These observations are consistent with maturation of multiple ovarian follicles, a surprising finding considering the normal gonadotropin concentrations. The retarded development of the endometrium in the presence of supranormal serum E2 and progesterone concentrations is a morphologic demonstration of the antiprogestational effect of antiestrogens. The lack of gonadotropin suppression in the presence of hyperestrogenemia suggests a major antiestrogen action on the hypothalmus and pituitary gland.
PIP: Administration of antiestrogen has recently been incorporated into the management of breast cancer. To explore the endocrine consequences of this therapy 5 healthy premenopausal volunteers were observed and treated with daily administration of the antiestrogen Tamoxifen. During the treatment period all subjects continued to have regular menses and basal body temperature; estradiol (E2) levels increased but followed a regular pattern, and its concentration at midcycle and during the luteal phase were twice as high as during nontreatment. On the other hand, concentrations of LH and of ESH were not greatly changed. In the presence of higher concentrations of E2 and of progesterone the endometrium showed a retarded development, thus demonstrating the antiprogestational effect of Tamoxifen. The lack of gonadotropin suppression also suggests a major antiestrogen action on the hypotalamus and pituitary glands.
Similar articles
-
Atypical estradiol secretion and ovulation patterns caused by luteal out-of-phase (LOOP) events underlying irregular ovulatory menstrual cycles in the menopausal transition.Menopause. 2009 Jan-Feb;16(1):50-9. doi: 10.1097/GME.0b013e31817ee0c2. Menopause. 2009. PMID: 18978637
-
Hormonal profile in IUD users.Contracept Deliv Syst. 1981 Oct;2(4):303-10. Contracept Deliv Syst. 1981. PMID: 12336991
-
Endocrinology of female infertility.Br Med Bull. 1979 May;35(2):193-8. doi: 10.1093/oxfordjournals.bmb.a071569. Br Med Bull. 1979. PMID: 387167 Review.
-
Features of the normal menstrual cycle.J Toxicol Environ Health. 1977 Sep;3(1-2):123-30. doi: 10.1080/15287397709529552. J Toxicol Environ Health. 1977. PMID: 336898 Review.
-
Pituitary responsiveness to LHRH and TRH in adolescent girls.Bull Schweiz Akad Med Wiss. 1978 Mar;34(1-3):241-54. Bull Schweiz Akad Med Wiss. 1978. PMID: 96896
Cited by
-
Strong Evidences of the Ovarian Carcinoma Risk in Women after IVF Treatment: A Review Article.Iran J Public Health. 2019 Dec;48(12):2124-2132. Iran J Public Health. 2019. PMID: 31993380 Free PMC article. Review.
-
The effect of tamoxifen therapy on the endometrium and ovarian cyst formation in patients with breast cancer.Obstet Gynecol Sci. 2018 Sep;61(5):615-620. doi: 10.5468/ogs.2018.61.5.615. Epub 2018 Aug 13. Obstet Gynecol Sci. 2018. PMID: 30254998 Free PMC article.
-
Cohort Profile: the Predictors of Breast Cancer Recurrence (ProBe CaRE) Premenopausal Breast Cancer Cohort Study in Denmark.BMJ Open. 2018 Aug 1;8(7):e021805. doi: 10.1136/bmjopen-2018-021805. BMJ Open. 2018. PMID: 30068618 Free PMC article.
-
The influence of tamoxifen on normal mouse mammary gland homeostasis.Breast Cancer Res. 2014 Jul 24;16(4):411. doi: 10.1186/s13058-014-0411-0. Breast Cancer Res. 2014. PMID: 25056669 Free PMC article.
-
Metabolism and transport of tamoxifen in relation to its effectiveness: new perspectives on an ongoing controversy.Future Oncol. 2014 Jan;10(1):107-22. doi: 10.2217/fon.13.168. Future Oncol. 2014. PMID: 24328412 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources